» Articles » PMID: 35535173

Genetic Variation in and Its Association with Bone Mineral Density, Fractures and Osteoporosis in Children with Bone Fragility

Overview
Journal Bone Rep
Date 2022 May 10
PMID 35535173
Authors
Affiliations
Soon will be listed here.
Abstract

Several genome-wide association studies (GWAS), GWAS meta-analyses, and mouse studies have demonstrated that wingless-related integration site 16 (WNT16) gene is associated with bone mineral density (BMD), cortical bone thickness, bone strength and fracture risk. Practically no data exist regarding the significance of WNT16 in childhood-onset osteoporosis and related fractures. We hypothesized that pathogenic variants and genetic variations in could explain skeletal fragility in affected children. We screened the gene by Sanger sequencing in three pediatric cohorts: 35 with primary osteoporosis, 59 with multiple fractures, and in 95 healthy controls. Altogether, we identified 12 variants in . Of them one was a rare 5'UTR variant rs1386898215 in genome aggregate and medical trans-omic databases (GnomAD, TOPMED; minor allele frequency (MAF) 0.00 and 0.000008, respectively). One variant rs1554366753, overrepresented in children with osteoporosis (MAF = 0.06 healthy controls MAF = 0.01), was significantly associated with lower BMD. This variant was found associated with increased gene expression at mRNA level in fibroblast cultures. None of the other identified variants were rare (MAF < 0.001) or deemed pathogenic by predictor programs. WNT16 may play a role in childhood osteoporosis but genetic variation is not a common cause of skeletal fragility in childhood.

Citing Articles

Wnt16 Promotes Vascular Smooth Muscle Contractile Phenotype and Function via Taz (Wwtr1) Activation in Male LDLR-/- Mice.

Behrmann A, Zhong D, Li L, Xie S, Mead M, Sabaeifard P Endocrinology. 2023; 165(2).

PMID: 38123514 PMC: 10765280. DOI: 10.1210/endocr/bqad192.


Association between AXIN1 gene polymorphism (rs9921222) of WNT signaling pathway and susceptibility to osteoporosis in Egyptian patients: a case-control study.

Nassar E, Elnemr R, Shaaban A, Abd Elhameed A, Taleb R BMC Musculoskelet Disord. 2023; 24(1):527.

PMID: 37380960 PMC: 10303865. DOI: 10.1186/s12891-023-06644-y.

References
1.
Correa-Rodriguez M, Schmidt Rio-Valle J, Rueda-Medina B . Polymorphisms of the WNT16 gene are associated with the heel ultrasound parameter in young adults. Osteoporos Int. 2015; 27(3):1057-1061. DOI: 10.1007/s00198-015-3379-4. View

2.
Zhu X, Bai W, Zheng H . Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications. Bone Res. 2021; 9(1):23. PMC: 8085014. DOI: 10.1038/s41413-021-00143-3. View

3.
Laine C, Chung B, Susic M, Prescott T, Semler O, Fiskerstrand T . Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG). Eur J Hum Genet. 2011; 19(8):875-81. PMC: 3172925. DOI: 10.1038/ejhg.2011.42. View

4.
Chesi A, Wagley Y, Johnson M, Manduchi E, Su C, Lu S . Genome-scale Capture C promoter interactions implicate effector genes at GWAS loci for bone mineral density. Nat Commun. 2019; 10(1):1260. PMC: 6425012. DOI: 10.1038/s41467-019-09302-x. View

5.
Moverare-Skrtic S, Henning P, Liu X, Nagano K, Saito H, Borjesson A . Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat Med. 2014; 20(11):1279-88. PMC: 4392888. DOI: 10.1038/nm.3654. View